Article

Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratories, and treatment history

2026-04-01

Abstract excerpt

Prognostic stratification in multiple myeloma (MM) relies on staging systems that assign patients to fixed categories at diagnosis and discard the temporal information that accumulates during treatment. We developed a dynamic multimodal framework that predicts residual overall survival using observation windows ranging from 1 to 18 months post-diagnosis. The model integrates DeepInsight-transformed gene expression...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 73ca50a7-942b-53e8-9d89-b7dbfdce6ff9
DOI: 10.64898/2026.03.30.715136

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratories, and treatment historyDOI 10.64898/2026.03.30.715136Read

Unsupervised Multiomics Integration Identifies Prognostic Subtypes and Druggable Vulnerabilities in Multiple MyelomaSemantic proximity Read

Individualized dynamic risk assessment for multiple myelomaSemantic proximity Read

Machine Learning Models for Predicting Multiple Myeloma Staging and MGUS Progression Using Gene Expression DataSemantic proximity Read

Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasoneSemantic proximity Read

RNAseq-Based Machine Learning Models for Prognostication of Multiple MyelomaSemantic proximity Read

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging SystemSemantic proximity Read

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patientsSemantic proximity Read

Translating multi-omics complexity into sparse prognostic biomarkers for multiple myelomaSemantic proximity Read

Deep Transcriptome Profiling of Multiple Myeloma Using Quantitative Phenotypes.Semantic proximity Read

Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive diseaseSemantic proximity Read

A Comprehensive Targeted Panel of 295 Genes: Unveiling Key Disease Initiating and Transformative Biomarkers in Multiple MyelomaSemantic proximity Read

Deep transcriptome profiling of multiple myeloma with quantitative measures using the SPECTRA approachSemantic proximity Read